Abstracto
Gene Expression Monitoring in Pediatric Heart Transplant recipients
S S Goonewardene and PRajjayabunAlloMap gene expression testing is a non-invasive screening tool approved for use in heart transplant recipients age 15 and older. Experience with AlloMap in pediatric heart transplant recipients is limited. We sought to describe the variations in AlloMap scores seen in pediatric heart transplant recipients.
Descargo de responsabilidad: este resumen se tradujo utilizando herramientas de inteligencia artificial y aún no ha sido revisado ni verificado.